Yangsheng Qiu

Title: The Innovative Contributions of Yangsheng Qiu

Introduction

Yangsheng Qiu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of five patents to his name, Qiu's work has the potential to impact various medical applications.

Latest Patents

Among his latest patents, Qiu has developed anti-CD39 antibodies, which include isolated polynucleotides encoding these antibodies, pharmaceutical compositions, and their uses. Another notable patent involves CD47 antigen binding units, which specifically bind to CD47. This patent also discloses polynucleic acids encoding these binding units, vectors comprising said polynucleic acids, and methods for inducing phagocytosis of CD47-expressing cells.

Career Highlights

Yangsheng Qiu has worked with notable companies such as GlaxoSmithKline Intellectual Property Development Limited and Elpiscience (Suzhou) Biopharma, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of biopharmaceuticals.

Collaborations

Qiu has collaborated with esteemed colleagues, including Tejinder Kaur Bhinder and Chong Ding. These partnerships have fostered an environment of innovation and have led to the advancement of various projects in biotechnology.

Conclusion

Yangsheng Qiu's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in therapeutic treatments.